Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

BUSINESS COMBINATIONS - Disclosure of detailed information about cash outflow/inflow on the acquisition (Details)

v3.21.1
BUSINESS COMBINATIONS - Disclosure of detailed information about cash outflow/inflow on the acquisition (Details) - Mar. 15, 2019 - Adjupharm GmbH ("Adjupharm") [Member]
€ in Thousands, $ in Thousands
CAD ($)
EUR (€)
Disclosure of detailed information about business combination [line items]    
Cash and cash equivalents acquired with the acquiree at the acquisition date $ 84  
Cash paid (1,400) € (924)
Net cash outflow $ (1,316)